Tirzepatide noninferior to dulaglutide with respect to composite of death from cardiovascular causes, myocardial infarction, or stroke.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “Type 2 myocardial infarction occurs due to a mismatch ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Causes of MI such as hypoxemia and anemia, also tied to ...
HealthDay News — For patients with type 2 diabetes, the risk of acute myocardial infarction (AMI) is not significantly different for long-acting insulin analogs versus other basal insulin therapies, ...
The hospital and post-discharge course of patients diagnosed with type-2 myocardial infarction (MI), triggered when myocardial oxygen demand outstrips supply, differs in telling ways from those with ...
Sotagliflozin, a dual SGLT1/2 inhibitor, shows benefit specifically for reducing myocardial infarction and stroke risks. Among patients with type 2 diabetes and chronic kidney disease (CKD) at ...
Type 2 myocardial infarction (T2MI) occurs less frequently than type 1 myocardial infarction (T1MI) among patients presenting to the emergency department with chest pain, but clinical outcomes for the ...
Rates of type 1 myocardial infarction (T1MI) have markedly declined as compared with rates of type 2 MI (T2MI), such that by the end of a new study's 10-year reporting period rates of both types of ...
Among individuals aged 50 years or younger who experienced an initial myocardial infarction (MI), those with type 2 MI had significantly higher long-term all-cause and cardiovascular mortality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results